ClinicalTrials.gov record
Recruiting Phase 3 Interventional Accepts healthy volunteers

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

ClinicalTrials.gov ID: NCT07280065

Public ClinicalTrials.gov record NCT07280065. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Diagnostic Testing of Post-Traumatic Stress Disorder (PTSD) Using the Senseye Diagnostic Tool in Adults : United States, Australia, and Decentralized Trial (DCT) Protocol

Study identification

NCT ID
NCT07280065
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Senseye, Inc.
Industry
Enrollment
1,900 participants

Conditions and interventions

Interventions

  • Clinician Administered PTSD Scale for DSM-5, Revised Version Behavioral
  • Senseye Diagnostic Tool (DT) Device

Behavioral · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 22, 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026
Last update posted
Apr 21, 2026

2026

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 Recruiting
Savannah VA Clinic Savannah Georgia 31419 Not yet recruiting
Velocity Clinical Research Meridian Idaho 83642 Recruiting
Lindus Health (Virtual Study Site) Boston Massachusetts 02111 Recruiting
Lowcountry Center for Veterans Research Charleston South Carolina 29403 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07280065, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07280065 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →